MISSION: IMPOSSIBLE; The First Randomized Trial in Asymptomatic Patients with Severe Organic Mitral Valve Regurgitation

References

• Baumgartner H , Falk V , Bax JJ , et al. 2017 ESC/EACTS Guidelines for the managementof valvular heart disease. Eur Heart J . 2017;38:2739–2791. doi:10.1093/eurheartj/ehx391.
   PubMed Web of Science ®Google Scholar
• Rosenhek R , Rader F , Klaar U , et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation . 2006;113:2238–2244. doi:10.1161/CIRCULATIONAHA.105.599175.
   PubMed Web of Science ®Google Scholar
• Nishimura RA , Otto CM , Bonow RO , et al. 2017 AHA/ACC Focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol . 2017;70:252–289. doi:10.1016/j.jacc.2017.03.011.
   PubMed Web of Science ®Google Scholar
• Enriquez-Sarano E , Avierinos JF , Messika-Zeitoun D , et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Eng J Med . 2005;352:875–883. doi:10.1056/NEJMoa041451.
   PubMed Web of Science ®Google Scholar
• Montant P , Chenot F , Robert A , et al. Long-term survival in asymptomatic patients severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg . 2009;138:1339–1348. doi:10.1016/j.jtcvs.2009.03.046.
   PubMed Web of Science ®Google Scholar
• Kang DH , Park SJ , Sun BJ , et al. Early surgery versus conventional treatment for asymptomatic severe mitral regurgitation: a propensity analysis. J Am Coll Cardiol . 2014;63:2398–2407. doi:10.1016/j.jacc.2014.02.577.
   PubMed Web of Science ®Google Scholar
• Ye J , Jamieson WR. The real impact of randomised clinical trials in heart valve surgery. Curr Opin Cardiol . 2006;21:106–112. doi:10.1097/01.hco.0000210306.79607.1b.
   Web of Science ®Google Scholar
• Tietge WJ , De Heer LM , Van Hessen MW , et al. Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organic mitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial. Neth Heart J . 2012;20:94–101. doi:10.1007/s12471-012-0249-y.
   PubMed Web of Science ®Google Scholar
• Jansen R , Kluin J , Chamuleau SA. Research versus clinical practice in asymptomatic patients with severe organic mitral regurgitation and preserved LV function. J Am Coll Cardiol . 2014;64:1639–1640. doi:10.1016/j.jacc.2014.07.964.
   PubMed Web of Science ®Google Scholar
• Jansen R , Kluin J , Ray SG , et al. Identification of the asymptomatic patient with severe mitral regurgitation: discrepancy between research and clinical practice. Cardiol Rev . 2017;25:110–116. doi:10.1097/CRD.0000000000000119.
   PubMed Web of Science ®Google Scholar
• Gardner TJ , O’Gara PT . The cardiothoracic surgery network: randomized clinical trials in the operating room. J Thorac Cardiovasc Surg . 2010;139:830–834. doi:10.1016/j.jtcvs.2010.02.001.
   Web of Science ®Google Scholar
• Bridgewater B , Hooper T , Munsch C , et al. Mitral repair best practice: proposed standards. Heart . 2006;92:939–944. doi:10.1136/hrt.2005.076109.
   PubMed Web of Science ®Google Scholar